PAE vs TURP: How the Two Prostate Procedures Compare

TURP remains the stronger procedure for improving urinary flow and reducing prostate volume, but PAE offers a less invasive alternative with a shorter hospital stay, fewer sexual side effects, and lower upfront cost. The gap between the two has narrowed as embolization techniques have improved, and randomized trials now show that symptom scores can end up in a similar range even when the objective measurements favor TURP. Choosing between them depends heavily on what you prioritize: maximum urinary improvement or a gentler recovery with fewer impacts on ejaculatory function.

How the Two Procedures Work

TURP is the older and more established option. A surgeon passes an instrument through the urethra and shaves away excess prostate tissue that has been blocking urine flow. It physically removes the obstruction, and the tissue can be sent for pathology. The procedure requires spinal or general anesthesia and typically involves a hospital stay of one to three days with a urinary catheter in place during initial recovery.

PAE is performed by an interventional radiologist rather than a urologist. A small catheter is threaded through the femoral or radial artery and guided into the prostatic arteries using real-time imaging. Tiny particles are injected to block blood flow to portions of the prostate, which causes the tissue to shrink over subsequent weeks through a combination of ischemia, cell death, and reduced smooth-muscle tone. The prostate is not physically removed; it atrophies in place.¹ PAE is usually done under local anesthesia with sedation, and many patients go home the same day or the following morning.

Symptom Scores and How They Compare

The metric most trials use to measure symptom improvement is the International Prostate Symptom Score (IPSS), a questionnaire that rates urinary bother on a scale from 0 to 35. Both PAE and TURP substantially reduce IPSS scores, but the results are not identical.

A Swiss randomized trial published in the BMJ found that at 12 weeks, IPSS dropped by about 9 points after PAE and about 11 points after TURP. The difference of roughly 1.5 points favored TURP but was not statistically significant. The trial could not formally establish that PAE was noninferior to TURP, though, because individual outcomes varied widely.² At two years in the same trial, TURP’s advantage grew: the flow-rate improvement, prostate volume reduction, and residual urine volume all favored TURP by a significant margin.³

By five years, the same cohort showed an IPSS reduction of about 8 points for PAE versus nearly 12 points for TURP. The roughly 4-point gap still did not reach statistical significance, but the trend was consistent: TURP delivered a bigger and more durable drop in symptoms.⁴ A separate randomized trial reported more comparable symptom improvements at 12 months, with IPSS reductions of about 21 points for PAE and 18 points for TURP, though that trial also could not formally prove noninferiority for urine-flow measures.⁵

Urine Flow and Prostate Shrinkage

This is where TURP pulls ahead most clearly. Peak urinary flow rate, measured as maximum flow in milliliters per second, is an objective gauge of how well urine moves. A meta-analysis pooling five randomized trials found that TURP produced significantly better flow-rate improvement than PAE.⁶ Individual trials tell the same story: at two years, the Swiss trial measured flow-rate gains of about 4 mL/s for PAE compared with about 10 mL/s for TURP.⁷

Prostate volume shrinkage also favors TURP, and by a wide margin. In a head-to-head comparative study, the mean volume reduction was around 31 to 37 grams for TURP (depending on the technology used), compared with about 11 grams for PAE.⁸ That makes sense: TURP physically removes tissue, while PAE only shrinks it partially through reduced blood supply.

One interesting nuance is post-void residual urine, the volume left in the bladder after urinating. In pooled data, the difference between PAE and TURP for residual urine reduction did not reach statistical significance.⁹ So while TURP wins decisively on flow rate and volume reduction, the gap narrows for some outcome measures that matter in daily life.

Sexual Function and Ejaculatory Effects

This is PAE’s strongest selling point. TURP is notorious for causing retrograde ejaculation, a condition where semen enters the bladder during orgasm instead of exiting through the penis. Retrograde ejaculation after TURP is common and often permanent. While not dangerous, many men find it distressing, and for those still hoping to father children, it is a serious concern.

PAE causes far less ejaculatory disruption. In a reassessment of two prospective trials, ejaculatory function declined after both procedures, but the deterioration was significantly more pronounced after TURP. Patients rated their bother from ejaculatory problems at nearly zero after PAE, compared with a moderate level of bother after TURP, and that difference persisted at a median follow-up of over two years.¹⁰ For men who place high value on preserving sexual function, the advantage of PAE is substantial and well documented.

Safety, Complications, and What Can Go Wrong

Each procedure carries a different risk profile, and neither is risk-free.

TURP’s historical complications include bleeding that sometimes requires transfusion, so-called TUR syndrome (a potentially dangerous drop in blood sodium caused by absorption of irrigation fluid), blood clots in the bladder, and urinary tract infections. Advances in instrumentation have reduced these rates sharply. Modern series report transfusion rates below 1%, TUR syndrome near 0% with bipolar equipment, clot retention around 2%, and infection rates under 2%.¹¹ Long-term risks include urethral stricture and bladder-neck contracture, which can develop months or years later and sometimes require additional procedures. Bipolar TURP has largely eliminated TUR syndrome by using saline irrigation instead of glycine, though monopolar systems are still used in many centers and still carry that risk.¹²

PAE’s complication profile looks different. Because no tissue is cut, bleeding and TUR syndrome are not concerns. The most frequently reported issues are transient pelvic pain, blood in the urine, and urinary-tract symptoms that flare temporarily as the prostate swells before shrinking. A more serious but uncommon risk is non-target embolization, where particles drift into arteries that supply other structures. In the UK-ROPE observational study, two patients developed self-limiting penile ulcers from inadvertent embolization of nearby vessels.¹³ Rectal ischemia has been reported in rare cases as well, though improvements in imaging guidance have made this less likely.

Recovery Time and Hospital Stay

PAE wins clearly here. A large comparative study using registry data found that PAE patients were discharged an average of 2.6 days earlier than TURP patients, and they had lower rates of in-hospital urinary retention (about 3% versus 7%).¹⁴ Many PAE centers perform the procedure as a day case or with a single overnight stay. TURP typically requires a catheter for one to three days postoperatively, and patients are generally advised to avoid strenuous activity for several weeks. After PAE, most men return to normal activities within a few days, though urinary symptoms may fluctuate during the first month as the prostate gradually shrinks.

When PAE Might Be the Better Choice

PAE is not a universal replacement for TURP, but certain clinical scenarios tilt the balance in its favor. Men who are poor surgical candidates due to cardiovascular disease, bleeding disorders, or anticoagulant use often do better with PAE because it avoids general or spinal anesthesia and carries minimal bleeding risk. Patients who place a premium on preserving ejaculatory function, including younger men or those who are sexually active and concerned about retrograde ejaculation, frequently prefer PAE for the reasons discussed above.

Prostate size also matters. PAE appears to be particularly effective in men with large prostates (above roughly 80 cubic centimeters), where TURP can become technically challenging and riskier due to longer operative time and greater blood loss.¹⁵ In these larger glands, PAE’s proportional volume reduction can still produce meaningful symptom relief even though the absolute shrinkage is less dramatic than what TURP achieves in smaller prostates.

When PAE Is Not Feasible

Not every man can have PAE, even if he wants it. The procedure depends on navigating a catheter through the pelvic arteries and selectively reaching the prostatic vessels, and the anatomy does not always cooperate. Severe atherosclerosis or heavy calcification along the iliac arteries can make catheter access impossible. One study found that technical failure was significantly associated with the number and extent of calcified lesions along the vascular route, as well as excessive iliac artery tortuosity.¹⁶ That is why pre-procedural CT angiography is standard: it maps the blood vessels and identifies men in whom embolization is unlikely to succeed.

Beyond vascular anatomy, established exclusion criteria for PAE include confirmed prostate cancer, large bladder stones or diverticula, active urinary-tract infection, chronic renal failure, and uncontrolled coagulation disorders.¹⁷ Men with suspected or confirmed malignancy are generally steered toward TURP or other surgical options, in part because TURP provides tissue for histologic examination while PAE does not.

Radiation Exposure During PAE

One factor that rarely comes up in patient conversations but deserves mention is radiation. PAE is a fluoroscopy-guided procedure, which means you are exposed to X-rays throughout. A systematic review found that the average radiation dose during PAE corresponds to a lifetime cancer-death probability of roughly 0.1% for a typical 66-year-old patient, with leukemia accounting for the largest share of that risk.¹⁸ For an older man already dealing with significant urinary symptoms, that is a small additional risk. But there is wide variation between centers: median dose-area products in published studies ranged from about 33 to over 860 Gy·cm², suggesting that technique and equipment quality make a big difference.¹⁹ Use of cone-beam CT during the procedure, while adding contrast and some extra radiation, has been associated with slightly better procedural planning overall.²⁰ TURP, by contrast, involves no ionizing radiation at all.

Cost Differences

PAE tends to be cheaper upfront, primarily because it avoids operating-room time and requires a shorter hospital stay. A UK cost-utility analysis found that PAE was cheaper than TURP at one year, though the study also noted that TURP delivered more quality-adjusted life-years, meaning the cost savings came with a slight trade-off in outcomes.²¹ A US-based Markov model estimated that the overall cost of PAE was about $6,500 compared with roughly $9,200 for TURP, and concluded that PAE was cost-effective given a standard willingness-to-pay threshold.²²

An important caveat: these analyses typically cover one to five years. If PAE’s symptom improvement fades faster over time and more men need a repeat procedure or a subsequent TURP, the long-run cost gap could shrink or even reverse. The five-year Swiss trial data showed that some PAE patients eventually crossed over to TURP, and any future cost analyses will need to factor in retreatment rates to give a full picture.

The Retreatment Question

One of the biggest unresolved questions is how often PAE patients eventually need another procedure. Because PAE shrinks rather than removes tissue, the gland can continue to grow over time, potentially requiring a second embolization or a surgical procedure down the road. TURP creates a more definitive channel through the prostate, and while regrowth can happen there too, the retreatment rate is lower in long-term data. The five-year Swiss trial is the longest direct comparison published so far, and while it showed that PAE patients fared reasonably well at five years in terms of symptom scores, the trend toward widening differences in objective measures suggests that some PAE patients will eventually need additional intervention.²³ Ten-year comparative data do not yet exist, so the durability question remains genuinely open.

What the Different Medical Specialties Think

It is worth knowing that PAE and TURP are performed by different kinds of doctors, and each specialty has a somewhat predictable perspective. Urologists perform TURP and tend to emphasize the superior objective outcomes (flow rates, volume reduction) and the longer track record. Interventional radiologists perform PAE and tend to highlight the shorter recovery, lower complication rates, and sexual-function preservation. Both groups are citing real data, but the emphasis shifts depending on who you ask.

Major urology guidelines in Europe and the United States have been cautious about PAE, generally listing it as an option for men who are not surgical candidates or who decline surgery, rather than as a first-line equivalent to TURP. Interventional radiology societies, meanwhile, have issued more enthusiastic endorsements. The practical takeaway is that getting opinions from both a urologist and an interventional radiologist before making a decision is worthwhile. Their recommendations may differ, and understanding why helps you make a more informed choice based on what matters most to you personally: maximum symptom relief, preservation of sexual function, avoidance of anesthesia, or recovery speed.

Availability and Access

TURP is available at virtually every hospital with a urology department. It has been performed for decades and is part of standard urological training worldwide. PAE, by contrast, requires specialized interventional radiology expertise and high-quality fluoroscopy equipment. Not every hospital offers it, and in many regions, the closest PAE center may be a significant distance away. The procedure also has a steeper learning curve tied to vascular anatomy: prostatic arteries are small and variable, and the operator’s experience with microcatheter navigation matters for both success rates and safety. If you are considering PAE, asking about the center’s case volume and the radiologist’s experience is reasonable and encouraged. Centers that perform PAE regularly tend to report better technical success rates and lower complication rates than those that do it occasionally.